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ABSTRACT 
 
Microbial Impacts on Endocrine Disrupting Contaminants: Las Vegas Wash and 
Lake Mead, NV 
 
by 
 
Susanna May Blunt 
 
Dr. Brian P. Hedlund, Examination Committee Chair 
Associate Professor of Biology 
University of Nevada, Las Vegas 
 
Dr. Duane P. Moser, Committee Co-Chair 
Associate Professor of Microbiology, Division of Earth and Ecosystems Sciences 
Desert Research Institute 
 
 
International concern over endocrine disrupting chemicals (EDCs) has become 
heightened in recent years as more studies reveal their persistence in the environment and 
their detrimental effects on wildlife.  However, little is known about the role of 
microorganisms in the fate and transport of these compounds in surface waters.  Las 
Vegas Wash, a stream flowing into Lake Mead and fed primarily by treated wastewater 
effluent, provided a unique experimental system in which to study the role 
microorganisms play in the dispersal of these compounds in aquatic systems.  Samples 
were collected from the Las Vegas Wash downstream of the Las Vegas Valley’s three 
wastewater treatment plants, in Las Vegas Bay near the confluence of the Las Vegas 
Wash and Lake Mead, at the Drinking Water Intake site, and at the Colorado River where 
it enters Lake Mead.  The biodegradation potential of 27 pharmaceuticals and EDCs was 
examined utilizing native microorganisms in microcosms from the four water samples 
over a 120 day period.  Chemical analysis at the end of the incubation revealed that the 
iv 
 
Las Vegas Wash site experienced the greatest removal, with 72% total mass reduction of 
the parent compounds.  With the exception of the bacteriostatic control, the Colorado 
River site experienced the lowest degradation, with only 37% removal.  Similarly, Biolog 
Ecoplate assays demonstrated that the Las Vegas Wash was able to use a considerably 
greater number of carbon substrates than any other site. Finally, microbial community 
composition analysis based on 16S rRNA gene censuses using Unifrac and LIBSHUFF 
statistical methods revealed the Las Vegas Wash community to be significantly distinct 
from other sampled locations, although all sites were similar with regard to overall 
diversity and richness.  The results indicated that the Las Vegas Wash microbial 
community contained a broader metabolic potential for EDC biodegradation.  This was 
further supported by phylogenetic analysis identifying a high number of phylotypes 
related to known isolates able to catabolize similar compounds.   
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CHAPTER 1 
INTRODUCTION 
 Emerging contaminants are a topic of increasing concern as studies reveal their 
persistence in the environment and the adverse effects they can have on wildlife.  Among 
these are endocrine disrupting chemicals (EDCs), which are defined as “exogenous 
chemical substances or mixtures that alter the structure or function(s) of the endocrine 
system and cause adverse effects at the level of the organism, its progeny, populations, or 
subpopulations” (USEPA, 1997).  Many commonly used synthetic chemicals, 
pharmaceuticals and personal care products are known or alleged EDCs, including the 
surfactants nonylphenol and octylphenol, the plastic additive bisphenol A (BPA), the 
pesticide atrazine, and the antimicrobial triclosan.  However, while some of these 
compounds have been confirmed to be estrogenic, they are several orders of magnitude 
lower in estrogenicity than the natural and synthetic steroid hormones 17β-estradiol (E2), 
estrone (E1), and 17α-ethinylestradiol (EE2), as shown in in vitro studies by Routledge & 
Sumpter (1996).  Chang et al. (2011) has suggested that natural estrogens such as E2 and 
estrone E1 are the primary compounds responsible for endocrine disruption in wildlife.  
In fact, some studies have attributed estrogens as the sole source for estrogenic effects in 
wastewater effluent (Desbrow et al. 1998).  Steroid hormones, including estrogens, are 
excreted through human waste and although 90% or more may be removed through 
activated sludge treatment (Joss et al. 2004), it appears that many EDCs still make their 
way into streams and waterways through wastewater effluent.  This can cause potential 
problems for wildlife downstream (Routledge et al. 1998).   
2 
 
The mechanisms driving the natural attenuation of wastewater-derived organic 
contaminants in the environment are poorly understood.  These compounds are regularly 
detected in surface and groundwaters around the world, including, but not limited to the 
U.S., Italy, UK, Sweden, Germany, China, and Israel (Bendz et al. 2005, Bester et al. 
2008, Kasprzyk-Hordern et al. 2009, Kolpin et al. 2002, Kuster et al. 2008, Petrovic et al. 
2004).  According to studies by the U.S. Geological Survey (USGS), prescription and 
over-the-counter pharmaceuticals, insect repellants, detergents, plasticizers, fire 
retardants, antibiotics, and hormones are the most frequently found EDCs in waterways 
nationwide (Barnes et al. 2008, Focazio et al. 2008).  Their ubiquity suggests that as a 
class of compounds, they are somewhat refractory.  However, the fate and transport of 
any individual compound is controlled by the relationship of biophysiochemical 
processes such as advection, photolysis, adsorption, desorption, and microbial 
degradation.  As global water resources become more strained by population growth, 
drought, and climate change, beneficial wastewater reuse practices will increase, making 
dwindling water resources more susceptible to contamination from these compounds 
(Benotti et al. 2010).  A better understanding of the fate and transport of wastewater-
derived organic contaminants will help identify which compounds may pose a particular 
threat to ecosystem or human health.   
 Specific subclasses of organic wastewater contaminants, pharmaceuticals and 
EDCs have been the focus of many recent studies on occurrence, and to a lesser extent, 
fate and transport mechanisms (Loffler et al. 2005, Winkler et al. 2001, Kreuzig et al. 
2003, Casey et al. 2004).  While the presence of these compounds in the environment is 
not a new phenomenon, recent advances in analytical instrumentation have allowed for 
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robust quantification to the low ng/L concentrations, thus revealing their ubiquity in 
wastewater streams (Vanderford et al. 2003, Kolpin et al. 2002).  Their presence in the 
environment has been implicated as a threat to the health of aquatic ecosystems, 
particularly in wastewater-dominated environments, as has been documented in the 
United Kingdom (Routledge et al. 1998) and the United States (Bevans et al. 1996, 
Snyder et al. 2010).  Pharmaceuticals and EDCs have also been detected in drinking 
water (Benotti et al. 2009), raising the possibility that these compounds may pose a risk 
to human health as well. 
Microorganisms are ubiquitous and largely responsible for the alteration and fate 
of many organic chemicals in the environment (Schwarzenbach 2003).  Most of the 
information pertaining to the biodegradability of EDCs stems from investigations of their 
behavior at wastewater treatment plants (WWTP) or during soil aquifer treatment (SAT), 
in which their removal is most often attributed to microbial activity (Chang et al. 2011).   
Many studies have specifically focused on removal of these compounds by means of 
biodegradation under WWTP conditions with the majority being conducted in laboratory 
or pilot scale sludge reactors under varying conditions of incubation length and 
temperature.  In a comprehensive study by Carballa et al. (2006), biodegradation of a 
suite of pharmaceuticals including sulfamethoxazole, carbamazepine, diazepam, 
diclofenac, EE2, ibuprofen, naproxen, and iopromide was examined after treatment in a 
pilot scale anaerobic digester with a sludge retention time (SRT) ranging from 6 to 20 
days under both mesophilic and thermophilic conditions.  While sulfamethoxazole was 
shown to be almost completely removed under both conditions, carbamazepine showed 
no degradation regardless of temperature.  Diazepam, diclofenac, EE2, ibuprofen, and 
4 
 
naproxen all showed moderate to high removal under both settings.  Trimethoprim 
biodegradation was examined by Junker et al. (2006) under lab scale WWTP conditions 
for three weeks, but no more than 1% removal was seen.  Conversely, Batt and others 
(2006) observed approximately 70% removal of the same compound under WWTP 
conditions with nitrifying activated sludge and a longer SRT of 49 days.  Fluoxetine 
biodegradation was studied by Kwon and Armbrust over a period of 30 days (2006), and 
270 days by Redshaw et al. (2008), with activated sludge and biosolid-amended soil 
inoculum, respectively.  However no removal was detected in either study.   
 Extrapolating the fate of pharmaceuticals and EDCs during WWTP conditions to 
that in surface water is difficult.  It is assumed that compounds that persist through SAT 
systems (e.g. sulfamethoxazole and carbamazepine, among others (Drewes et al. 2003, 
Drewes et al. 2002)), are resistant to biotransformation or biodegradation and should have 
slower rates of biodegradation in surface waters.  Conversely, compounds that are rapidly 
removed in SAT systems are often susceptible to biodegradation and should exhibit faster 
rates of biodegradation in surface waters.  One notable exception is caffeine.  Although 
caffeine is efficiently eliminated during wastewater treatment and rapidly attenuated 
during SAT, Buerge et al. (2003) demonstrated that it exhibited conservative behavior in 
surface waters and was an effective tracer of wastewater discharge.  Thus, there is the 
need to measure microbial degradation rates of pharmaceuticals and EDCs in surface 
waters as their behavior in specific systems may not accurately predict outcomes in 
others.   
In contrast to their behavior in WWTPs, relatively little is known about the 
microbial degradation or transformation of pharmaceuticals and EDCs in more natural 
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ecosystems.  Benotti et al. (2009) calculated first order degradation rates for low (ng/L) 
concentrations of pharmaceuticals in a wastewater-impacted estuary based on laboratory 
experiments.  Half-lives of the targeted compounds varied temporally and spatially 
throughout the estuary ranging from 0.68 to greater than 100 days.  Similarly, Yamamoto 
et al. (2009) calculated half-lives of eight pharmaceuticals in water collected from two 
rivers on two different dates.  In this work, half-lives attributed to microbial degradation 
ranged from 2.1 to 230 days and also varied spatially and temporally.  This variability in 
pharmaceutical half-lives, as well as the stark differences in degradation rates between 
time points in the Yamamoto study suggests that the microbial degradation of 
pharmaceuticals and EDCs is a dynamic phenomenon which varies by time and 
environment.  This variability may reflect the spatial and temporal differences in 
microbial populations in surface waters.   
A number of studies have investigated bacteria capable of estrogen degradation, 
particularly those isolated from sewage sludge.  Fujii et al. (2002) isolated a new 
Novosphingobium sp. from activated sludge capable of degrading E2, and Yu and others 
(2007) were able to isolate 14 E2-degrading bacteria from activated sludge, three of 
which were also able to degrade E1 which they suggested was due to nonspecific 
monooxygenase enzymes.  A study by Czajka and Londry (2006), investigating the 
anaerobic biodegradation of the estrogens E1, E2, and EE2 from river water samples, 
demonstrated biotransformation of E1 and E2 but with little actual mineralization of the 
steroid compounds.  Lee and Liu (2002) identified numerous metabolites and degradation 
pathways for E2 using a mixed culture of sewage bacteria and activated sludge 
supernatant.  In their experiments, transformation of E2 to E1 via oxidation at ring D of 
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E2 was observed.  This was followed by the transformation of E1 to a previously 
unnamed metabolite which they labeled X1, hypothesized to be a highly labile lactone.  
Actual elimination of E1 was observed after 14 days of incubation.  Jurgens and others 
(2002) demonstrated the biodegradation of E2 and EE2 by microorganisms in bulk river 
water samples with half-lives as low as several hours for E2 and up to 17 days for EE2.  
Using radiolabeled E2, their research revealed steroid ring cleavage of E2 at the A ring 
with a transient formation to E1 with subsequent complete mineralization. This is similar 
to results found by Coombe et al. (1966) whose experiments displayed the transformation 
pathways of E1 by Nocardia sp. (E110), a microorganism isolated from soil.  In their 
experiment E1 degradation occurred via cleavage of the A ring followed by the B ring.  
Their research also revealed the transformation of estrone to a pyridine carboxylic acid 
which they suggested was formed from either hydroxylation, oxidative fission via 
dioxygenase, or by nonenzymatic means, by a reaction with NH3.  Yi and others (2006), 
were able to show removal of EE2 using the ammonium monooxygenase enzyme which 
they obtained from a mixed culture of nitrifying microorganisms.    
  Although numerous studies have examined the biodegradation of EDCs and 
pharmaceuticals in WWTPs and SATs (Junker et al. 2006, Batt et al. 2006, Drewes et al. 
2002 and 2003), few studies have been performed which investigate the microbial 
communities or specific microbes involved in the biodegradation of the other less 
estrogenic compounds.  Cai et al. (2003) discovered an Arthrobacter sp. isolated from 
industrial wastewater capable of growing on atrazine as its sole nitrogen source.  Zhang 
et al. (2009) isolated two atrazine-degrading strains, including another Arthrobacter sp. 
and a Microbacterium sp., which demonstrated 66 and 78% degradation, respectively, 
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after 14 days in liquid culture.  Yamanaka et al. (2007) discovered three strains of BPA-
degrading bacteria (identified as Bacillus pumilis) from the traditional fermented food 
kimchi, capable of complete removal of BPA in liquid culture within 7 days.  Similarly, 
two Pseudomonas strains isolated from river water, including Pseudomonas putida and 
another Pseudomonas sp., were found to be capable of BPA degradation by Kang & 
Kondo (2002).  Gummadi and others (2009) were able to isolate a Pseudomonas strain 
from coffee plantation soil which could grow on caffeine as both a sole carbon and 
nitrogen source.  The compound N,N-diethyl-m-toluamide, better known as DEET,  a 
commonly used insect repellant, has been detected throughout numerous U.S. streams 
(Kolpin et al. 2002).  Rivera-Cancel et al. (2007) observed P. putida capable of growing 
aerobically on DEET as a sole carbon source and subsequently forming the metabolites 
3-methylbenzoate and diethylamine.  The antidepressant fluoxetine was investigated by 
Redshaw et al. (2008) and shown to be resistant to any form of biological degradation 
even after incubation in liquid cultures for 60 days and in sewage sludge-amended soils 
for greater than 200 days.  No known bacterial species capable of degrading fluoxetine 
have been isolated to date.   
There is a relative absence of studies examining microbial degradation of 
pharmaceuticals and EDCs in surface water systems while concurrently examining the 
microbial community composition which may be responsible for the degradation.  Las 
Vegas Wash and Lake Mead, ecosystems impacted by drought and anthropogenic point 
sources, provide unique environments to study the fate and degradation of EDCs by 
microorganisms while additionally assisting in understanding the factors involved in the 
persistence of these compounds in the environment.  Due to the fact that much of the Las 
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Vegas Valley’s treated wastewater flows through the Las Vegas Wash and into the 
Boulder Basin of Lake Mead, it is not surprising that various pharmaceuticals and EDCs 
including atrazine, DEET, diazepam, fluoxetine, progesterone, TCEP, and meprobamate 
have been found in in the Wash and Las Vegas Bay (Vanderford et al. 2003 and 
Trenholm et al. 2006).  Additionally, other studies have found steroid estrogens including 
E2 at concentrations as high as 2.7 ng/L (Snyder et al. 1999).  For perspective, 
concentrations of estrogens as low as 5 ng/L have been shown to cause total collapse of 
fish populations due to adverse effects on reproductive health (Kidd et al. 2007).  
Correspondingly, carp collected from Las Vegas Wash and Las Vegas Bay have been 
found to contain high concentrations of synthetic organic chemicals and significantly 
higher levels of endocrine disrupting biomarkers such as vitellogenin, an egg yolk 
precursor (Bevans et al. 1996).   
Lake Mead is the largest reservoir by volume in the United States and a principal 
water source for more than 25 million people in Nevada, Arizona, and California 
(Holdren & Turner 2010).  Inflows to Lake Mead include the Colorado River, the Virgin 
River, the Muddy River, and the aforementioned Las Vegas Wash (LaBounty & Burns 
2005).  Approximately 900 million gallons per day (MGD) of water is withdrawn from 
Lake Mead for Las Vegas residents, and approximately half is returned as treated 
wastewater via the Las Vegas Wash (LaBounty & Horn 1997, Drury et al. 2006).  The 
remaining water is lost to groundwater via irrigation and evapotranspiration.  Though the 
flow of the Las Vegas Wash to Lake Mead is relatively small (approximately 2.2%, 
Holdren & Turner 2010), it is almost entirely (90 percent) treated wastewater and 
represents a major point source discharge of wastewater-derived contaminants to Lake 
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Mead (Shanahan & Zhou 2011).  Thus, the Las Vegas Wash and Las Vegas Bay provide 
ideal sites to study microbial contaminant degradation in wastewater-impacted surface 
waters.  Moreover, it provides some insight into how microbial communities differ 
between a wastewater-dominated system (e.g. the Las Vegas Wash) and a contrasting 
environment with little wastewater influence (e.g. the Colorado River entering Lake 
Mead), as well as how differences in microbial communities relate to changes in relative 
rates of microbial degradation. 
 This study examined the primary microbial degradation rates of a diverse suite of 
pharmaceuticals and EDCs at four representative locations around Lake Mead, 
comparing the observed degradation patterns to characterizations of microbial 
composition, metabolism, and water quality characteristics.  The objectives were to: 
1. Investigate rates of EDC and pharmaceutical biodegradation along a gradient of 
highly wastewater-impacted to less impacted sites (Las Vegas Wash > Las Vegas 
Bay > Drinking Water Intake> Colorado River). 
2. Identify differences in bacterial abundance, diversity, community composition, 
and overall community metabolic activity between the four sites. 
This research will help elucidate characteristics of the microbial communities responsible 
for pharmaceutical and EDC biodegradation by evaluating the abundance, diversity, and 
metabolic capabilities at the individual sites.  Factors controlling the metabolisms of 
these compounds (i.e., microbial community structure and naturally occurring nutrient 
availability) will also be determined.  This information will assist in future risk 
assessments detailing the environmental fate and transport pathways of contaminants and 
their elimination via microbially-mediated processes. 
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CHAPTER 2 
MATERIALS AND METHODS 
Sampling Area 
Water samples were collected from four sites throughout Lake Mead and the Las 
Vegas Wash (Figure 2.1) on October 21 and 22, 2008 in coordination with routine water 
quality sampling by the Southern Nevada Water Authority (SNWA).  Each sample was 
collected using a peristaltic pump (Masterflex® E/S™ Portable Sampler, Cole-Parmer) 
and sterile platinum-cured silicone tubing (Masterflex® 96420-24, Saint-Gobain 
Performance Plastics Corporation) from shore (in the case of the Las Vegas Wash site), 
from a boat (in the case of the Las Vegas Bay and Colorado River Sites), or from a tap (in 
the case of the drinking water intake site.  The tap is connected to a water intake pipe 
which transfers raw water from Lake Mead to the Alferd Merrit Smith Drinking Water 
Treatment Facility (Boulder City, NV).  All samples were taken from within a meter of 
the surface with the exception of the drinking water intake which drew water from 
approximately 32 meters below the surface at the time of sampling.  Coordinates for the 
sites are as follows: Las Vegas Wash (36.092°N,-114.969°W), Las Vegas Bay 
(36.106°N,-114.780°W), Drinking Water Intake (36.064°N,-114.801°W), and Colorado 
River (36.100°N,-114.116°W).     
General chemical and physical parameters were measured at each site by SNWA 
and included temperature, dissolved oxygen concentration, pH, and specific conductance, 
using a multi-parameter sonde (Hydrolab Corporation Model Surveyor®).  Samples were 
also collected at each site to provide a comprehensive understanding of water chemistry 
parameters including major ions, metals, and nutrients.  Bottles for samples not requiring 
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preservatives were triple-rinsed with sample water before collections.  Sample bottles for 
metals, major ions and nutrients were prepared and analyzed by Weck Laboratories 
(Monrovia, CA) or SNWA.  Sterile bottles for bacterial heterotrophic plate counts 
(HPCs) were prepared and analyzed by SNWA Laboratory Support Services personnel 
according to in-house SOPs.  On site, samples for the microcosm experiments were 
pumped into 5 liter sterile glass carboys (Pyrex # CG-8106) containing a sterile teflon stir 
bar and having a hose-barbed tap and fitted with sterile tubing and “t” valves.  Prior to 
collection, the pump line was flushed with 5 liters of sample water and a 100 µm prefilter 
was fitted upstream of collection bottles to screen out larger debris and zooplankton.  All 
samples were maintained in a cooler on ice until distributed to the corresponding 
laboratory for analysis.   
 
 
Figure 2.1. Map of study site and sampling locations.  
 
Las Vegas 
Wash Site 
Las Vegas 
Bay Site 
Drinking Water 
Intake 
Upper Colorado 
River Site 
NEVADA ARIZONA 
LAKE MEAD 
Las Vegas Wash 
Virgin River Inflow Muddy River Inflow 
Hoover 
Dam/Colorado 
River Outflow 
Colorado 
River 
Inflow 
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Microcosm setup 
In the laboratory, carboys were capped with a sterile rubber stopper fitted with a 
0.2 µm filter to allow gas transfer and maintained in the dark (to prevent 
photodegradation) with gentle stirring at room temperature (Figure 2.2).  A total of six 
incubations were maintained, one for each of the four samples described above, and two 
controls: 1) Las Vegas Bay water with 1 g/L sodium azide as a bacteriostatic control and 
2) Las Vegas Bay water without pharmaceuticals and EDCs added to monitor microbial 
community responses to bottle effects.  Samples were collected from the four 
experimental incubations prior to EDC and pharmaceutical addition to determine native 
concentrations of EDCs and pharmaceuticals (Tables A.2 – A.5).  Each microcosm 
(except for the non-amended control) was amended with twenty-seven pharmaceuticals 
and EDCs (Table 2.1) to an initial concentration of 100-500 ng/L (see Appendix Tables 
A.6 – A.10 for actual concentrations).  Stock pharmaceuticals and EDCs were dissolved 
in sterile deionized (DI) water, rather than organic solvents, to prevent the unintentional 
introduction of organic matter, which might otherwise serve as a supplemental carbon or 
energy substrate in the incubations.  The low aqueous solubility of some of these 
compounds (e.g. the steroid hormones) precluded the entire stock from dissolving and 
explains some of the lower than desired initial concentrations.  Samples were collected 
using a “t” valve assembly for chemical analyses (including pharmaceuticals/EDCs and 
steroid hormones) and biological analyses (including terminal restriction fragment length 
polymorphism (T-RFLP), 16S rRNA gene libraries, flow cytometry, and community 
metabolism analysis using the Biolog Ecoplate assay).  At each time point, the oxygen 
content of the sample was checked using an Oxygen CHEMets® Kit (K-7512, 
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Chemetrics, Calverton, VA) to ensure that incubations were aerobic.  All sites remained 
stable with values between 6 and 7 mg/L with the exception of the bacteriostatic control 
which had slightly higher DO levels between 8 and 9 mg/L.  Time points for chemistry 
analysis included 0, 1, 2, 4, 7, 14, 29, 56, and 120 days. 
 
Fig 2.2. Microcosm setup showing the 4 representative sites with the 2 controls. 
 
Table 2.1.  Chemical names and structures of the spiked compounds. 
Compound Class Structure 
Diazepam Antianxiety 
 
Meprobamate Antianxiety 
 
Carbamazepine Anticonvulsant
 
Phenytoin Anticonvulsant
 
Primidone Anticonvulsant
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Compound Class Structure 
Caffeine Stimulant 
 
Fluoxetine Antidepressant 
 
Ibuprofen 
Nonsteroidal 
anti-
inflammatory  
Naproxen 
Nonsteroidal 
anti-
inflammatory  
Diclofenac 
Nonsteroidal 
anti-
inflammatory 
 
Atorvastatin Antilipidemic 
 
Gemfibrozil Antilipidemic 
 
Atenolol Beta blocker 
 
Iopromide 
Radiographic 
contrast 
medium 
 
Sulfamethoxazole Antibiotic 
 
Trimethoprim Antibiotic 
 
TCEP Flame retardant 
 
Bisphenol A Plastic component  
BHA Food preservative 
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Compound Class Structure 
Atrazine Herbicide 
 
DEET Insect repellant 
 
Triclosan Antimicrobial 
 
Estradiol Steroid hormone 
 
Estrone Steroid hormone 
 
Ethynylestradiol Steroid hormone 
 
Progesterone Steroid hormone 
 
Testosterone Steroid hormone 
 
 
Analytical Methods 
At each time point, 500 mL subsamples were collected into two 250 mL amber 
glass bottles, pre-amended with 0.25 g sodium azide.  One of each of the samples was 
analyzed for 1) pharmaceuticals and EDCs, and 2) steroid hormones.  Both analyses 
employ cleanup and sample concentration by solid phase extraction (SPE) and analysis 
by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS).  The 
pharmaceutical and EDC procedure is based on a method developed by Vanderford and 
Snyder (2006), and the steroid hormone procedure is based on a method developed by 
Trenhom et al. (2006) with the only differences being slightly modified analyte lists.  As 
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part of quality control measures for the SPE system, laboratory grade DI blanks and DI 
spiked samples were extracted alongside experimental samples.  Water samples were 
spiked with isotopically-labeled standards for isotope dilution quantitation of each of the 
target compounds analyzed and extracted using 5 cc glass, 200 mg, Oasis hydrophilic-
lipophilic balance (HLB) cartridges (Waters Corp., Milliford, MA), using the Autotrace 
automated SPE system (Zymark Cop., Hopkington, MA).  Cartridges were 
preconditioned with 5 ml each of dichloromethane, tert-butyl methyl ether, methanol and 
reagent water.  The water samples were then filtered through the cartridges at 15 ml/min, 
after which the cartridges were rinsed with 5 ml reagent water and dried with nitrogen 
gas for 60 minutes.  Samples were eluted with methanol, evaporated to 250 μl, and stored 
at -20°C until analysis.  LC/MS/MS analysis was performed using an Agilent G1312A 
(Palo Alto, CA) with a binary mobile phase of 0.1% formic acid in water and 100% 
methanol at a flow rate of 0.7 ml/min and an injection volume of 10 μl.  Mass 
Spectrometry was done with an Applied Biosystems API 4000 triple quadrupole mass 
spectrometer (Foster City, CA), using multiple reaction monitoring (MRM) with 
electrospray ionization (ESI) in positive and negative modes.  Method reporting limits 
(MRL) were three times the method detection limit (MDL). 
 
Microbial Characterization and Molecular Analysis 
Sample water for flow cytometric analysis was collected into sterile 15 ml conical 
polypropylene centrifuge tubes containing the preservative gluteraldehyde at a final 
concentration of 2.5%.  Total cell counts were performed using a MicroPRO™ flow 
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cytometer (“Total Biomass” assay, Advanced Analytical Technology Inc.) according to 
manufacturer designed methodologies. 
Cell biomass for DNA analysis was collected at each analytical time point by 
filtration onto 0.2 micron membrane filters (25 mm, Supor Polysulfone, Pall) from 100 
mL subsamples and stored at -80 °C.  DNA was extracted from archived filters using 
MoBio Ultraclean® Soil DNA kits (MoBio, Solano Beach, CA), and bacterial 
community analysis was conducted using terminal restriction fragment length 
polymorphism (T-RFLP, Liu et al., 1997) at Nevada Genomics Center in Reno, NV.  
Amplicons were generated using the polymerase chain reaction (PCR), using a FAM-
labeled forward primer (9bF, GRGTTTGATCCTGGCTCAG) and universal reverse 
(1512uR, ACGGHTACCTTGTTACGACTT) (Eder and Ludwig, 1999), on a PXE 0.2 
thermal cycler (Thermo Electron Corp., Milford, MA).  Fifty microliter PCR reactions 
contained 5 U LA Taq™ (Takara Bio Inc, Japan), 200 nmol/L of each primer, 8 μL of 2.5 
mM dNTP mixture, 5 μL of 10X LA PCR Buffer, 5 μL of 25 mM MgCl2, and 2 μL of 
DNA template.  Thermal cycler conditions included an initial denaturation step (5 min at 
95°C); 35 cycles of denaturation (30 s at 95°C), annealing (60 s at 50°C), and extension 
(90 s at 72°C); and a final elongation step of 20 min at 72°C.  PCR products were 
visualized in 1% agarose gels stained with 1 mg/mL ethidium bromide, run on a 
horizontal electrophoresis system (Owl Separation Systems, Portsmouth, NH) in 1X TAE 
buffer at 100 V for 45 min.  The crude product was submitted for purification and T-
RFLP analysis to the Nevada Genomics Center.  T-RFLP digests were performed using 
the restriction endonucleases HhaI and HaeIII (New England Biolabs, Ipswich, MA).   
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Patterns were analyzed using PeakScanner™ software (Applied Biosystems, Inc., 
Carlsbad, CA).   
For bacterial 16S rRNA gene library construction, PCR was performed in 3 
replicate 25 μL reaction mixtures for each sampling site to reduce PCR bias.  Bacterial 
primers 9bF and 1512uR were used and PCR products were purified (UltraClean™ 
GelSpin™ DNA Purification Kit, MoBio Laboratories, Inc.) and subjected to molecular 
cloning methodology using TOPO®-TA kits (Invitrogen).  Based on forward reads, 
clones representative of unique OTUs were bidirectionally sequenced (Functional 
BioSciences, Madison, WI) and contigs generated using Sequencher™ 4.8 (Gene Codes) 
and aligned, matched with nearest neighbors and checked for chimeras using Greengenes 
(DeSantis et al., 2006).  Alignments were refined and phylogenetic relationships 
determined using MEGA (Tamura et al., 2007).  Evolutionary history was inferred using 
the Maximum Likelihood method based on the Tamura-Nei model (Tamura & Nei, 
2003).  The tree with the highest log likelihood (-26421.8378) was used.  The initial tree 
for the heuristic search was obtained automatically as follows.  When the number of 
common sites was < 100 or less than one fourth of the total number of sites, the 
maximum parsimony method was used; otherwise BIONJ method with MCL distance 
matrix was used.  The analysis involved 218 nucleotide sequences.  All positions 
containing gaps and missing data were eliminated.  
 
 
Phylogenetic and Diversity Analysis 
 
Sequences from 16S rRNA gene libraries were clustered using the MOTHUR 
software package (Schloss et al. 2009) at operational taxonomic unit (OTU) cutoffs of 
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97%, 90%, and 80% using the average neighbor algorithm.  Diversity and richness 
indices including the Shannon diversity index (H’), the Simpson index, and Chao1 
richness estimator were also calculated in MOTHUR.  Evenness was calculated as 
H/Hmax, where H is the Shannon diversity estimate and Hmax = log2(S) with S being 
the total number of corresponding OTUs.  Community overlap and differences were also 
determined using rarefaction analysis.  LIBSHUFF was used in order to determine 
whether any statistically significant differences existed between sites (Schloss et al., 
2004). 
Community metabolic potential was assessed using Biolog EcoPlates (Biolog 
Inc., Hayward, CA) according to the manufacturer’s standard protocol.  Briefly, each 96 
well microtiter EcoPlate contains three replicates of 31 different carbon substrates and an 
additional three wells containing only water as a control.  As the various substrates are 
metabolized, a tetrazolium dye in each well produces a color change when reduced, 
which can then be measured using a microplate reader to provide optical density (OD595) 
values and subsequently quantified.  Approximately 10 mL of sample water from each of 
the four spatial sites were added to an EcoPlate at the beginning of the experiment and 
incubated at room temperature in the dark.  Absorbance readings at 595 nm were taken at 
intervals up to 12 days.  Averages were calculated from the 3 replicates and absorbance 
values above a threshold of 0.3 were considered positive for usage of the carbon source 
for that well.   
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CHAPTER 3 
RESULTS AND DISCUSSION 
Water Chemistry 
Table 3.1 shows the physical and chemical parameters at each site.  Las Vegas 
Wash had the highest temperature (23.4oC vs. 21.6 oC, 20.8 oC and 17.8 oC for the Bay, 
River and mid water column drinking water intake).  pH was slightly alkaline at all sites 
and highest at the river and LVB sites, at 8.38, and 8.27, respectively.  Dissolved oxygen 
(DO), 6.57 mg/L (LVW), 7.81 mg/L (LVB), and 5.87 mg/L (DWI), was under-saturated 
at all of the sites, except for the Colorado River, 8.57 mg/L. The lower temperature and 
DO concentrations at the drinking water intake are consistent with this site’s location at a 
greater depth within the reservoir.   
Overall, major ion concentrations were similar at three of the sites, LVB, DWI, 
and CR, and markedly higher in LVW.  Specifically, the relatively conservative cations, 
magnesium, sodium, and potassium, as well as the major anions, sulfate and nitrate were 
all much higher in the Las Vegas Wash.  The higher ion (salt) concentrations in the Wash 
are reflected in a much higher conductivity value (2,433 uS/cm, vs. 908 – 1,068 at the 
other sites) and are similar to previously reported data which were attributed to high 
evaporation rates at this site (Zhou et al. 2005).  The higher conductance values in Las 
Vegas Wash are consistent with data from LaBounty & Burns (2005), which showed a 
decreasing gradient in TOC and conductivity values from the inner basin where the Wash 
enters to sites within Lake Mead and on toward the Colorado River.    
A combined graphic expression of the water chemistry components in a Piper 
diagram (Figure 3.1) reveals that all sites group together, again with the exception of the 
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Las Vegas Wash, which is a slight outlier with respect to both cations and anions.  
Conversely, water from the drinking water intake and Colorado River sites plot on top of 
one another. 
 
Table 3.1. Water chemistry parameters 
 Las Vegas Wash 
Las Vegas 
Bay DW Intake 
Colorado 
River 
Temperature (°C) 23.4 21.6 17.8 20.8 
pH 7.71 8.27 7.93 8.38 
DO (mg/L) 6.57 7.81 5.87 8.57 
Conductivity (μS/cm) 2433 1068 1030 908 
TOC (mg/L) 6.0 3.2 2.7 2.9 
Tot. Alkalinity (mg/L) 129 132 143 134 
Nitrate (mg/L N) 14 0.88 0.5 0.2 
Nitrite (mg/L N) <0.05 <0.05 <0.05 <0.05 
T-Phosphate (mg/L P) 0.12 <0.005 <0.005 0.0055 
Ammonia (mg/L N) 0.205 0.024 <0.02 <0.02 
Calcium (mg/L) 130 75 81 69 
Chloride (mg/L) 340 100 88 80 
Iron (mg/L) <0.1 <0.1 <0.1 <0.1 
Magnesium (mg/L) 63 28 27 24 
Potassium (mg/L) 32 6.9 5.9 5 
Sodium (mg/L) 280 99 96 81 
Tot. Hardness (mg/L CaCO3) 590 300 320 270 
Alkalinity, CO3-2 0 0.592 0 2.39 
Alkalinity, HCO3- 129 131 143 131 
Silica (mg/L) 19 6.7 7.3 6.2 
Sulfate (mg/L) 570 270 250 220 
TDS (mg/L) 1541 649.4 618.4 553.6 
Turbidity (NTU) 2.68 0.51 0.33 2.66 
DO – Dissolved oxygen; TOC – total organic carbon; TDS – total dissolved solids 
 
Carbon, nitrogen, and phosphorus are nutrients which are vital for microbial 
growth and in some cases can have significant impacts on biodegradation rates 
(Schwarzenbach et al., 2003).  TOC, concentrations of wastewater-derived constituents 
such as nutrients (nitrate, phosphate, ammonium), and TDS were all considerably higher 
at the Las Vegas Wash site, but decrease spatially towards the Bay.  TOC levels in the 
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Wash were approximately double those at the other three sites (6.0 mg/L compared with 
2.7 - 3.2 mg/L), and nitrate was considerably higher in Las Vegas Wash (14.0 mg/L) than 
in the Bay,  DW Intake or Colorado River (0.88, 0.5, and 0.2 mg/L, respectively).  
Phosphate (as mg/L P) was only detected in the Las Vegas Wash and Colorado River 
(0.12 and 0.055), but was below detection limit at the other two sites.  This supports 
previously collected data which demonstrated that Lake Mead is extremely phosphorus 
limited (LaBounty and Horn 1997, Reginato and Peichota 2004, LaBounty 2005).  
 
Fig. 3.1. Piper diagram of the water chemistry from the four sampling sites.  Diagram 
was made using GW Chart (Version 1.23.5.0), a free software program available from the 
USGS.
 
LV Wash 
LV Bay 
DW Intake 
Colo River 
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Although the carbon, nitrogen, and phosphorus concentrations may be limiting 
factors for microbial activity and ultimately, biodegradation, it is less clear what 
concentrations of TOC may hinder (by providing competitive food sources) or assist 
(through cometabolism) microbial attenuation of xenobiotic compounds.  According to 
Cotner et al. 2010, aquatic bacteria (specifically those from freshwater lakes) are flexible 
in their nutrient requirements.  In their experiment, freshwater bacterial isolates grown 
under conditions of phosphorus limitation (875:179:1 C:N:P) produced bacterial biomass 
stoichiometries of 259:69:1, indicating that bacterial populations can subsist with nutrient 
ratios that diverge considerably from the commonly accepted Redfield ratio of C:N:P of 
106:16:1 (Redfield, 1934).  Chenier and others (2003) showed that the addition of carbon, 
nitrogen and phosphorus increased the mineralization of hexadecane by river water 
biofilms.  When no additional nutrients were added, mineralization was minimal, 
however, with the addition of 67 µM carbon, 80 µM nitrogen, and 5 µM phosphorus, up 
to 70% mineralization of hexadecane was observed after 42 days of incubation.  
Additionally, an experiment by Leys et al. (2005) noted that a molar C:N:P ratio of 
100:10:1 resulted in efficient polycyclic aromatic hydrocarbon (PAH) biodegradation 
although this rate was not affected when the C:N:P ratio was imbalanced by a lower 
molar N ratio (100:2:1), indicating that lower N conditions did not affect the 
biodegradation by the bacteria involved.  However, Rojas-Avelizapo et al. (2000) found 
that modifying the C:N:P ratio from 2700:140:1 to 100:10:1 caused an increase in the 
heterotrophic bacterial activity in soil but did not improve PCB degradation, although 
other researchers have found that adjusting this ratio can stimulate petroleum 
hydrocarbon degradation in contaminated soils and surface waters (Dibble and Bartha 
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1979, and Rogers et al. 1993).   Since these nutrients were not monitored throughout the 
time points of the experiment, the rate at which they were utilized is unknown, but the 
Las Vegas Bay and DW Intake microcosms may have been at a disadvantage due to the 
low initial phosphorus concentrations at these sites (<0.005 mg/L).   
 
 
 Transformation of Pharmaceuticals and EDCs 
Primary degradation (e.g. loss of parent compound) at each site varied 
considerably; however, the Las Vegas Wash microcosm showed the highest degradation 
capabilities of the four sites overall, with an aggregate 28% remaining of the compounds 
over the course of 120 days (Table 3.2).  This was followed by Las Vegas Bay with 49% 
remaining, the Drinking Water Intake with 60%, and the Colorado River site with 63%.  
The Las Vegas Bay Control microcosm exhibited markedly lower removal than the other 
4 sites, with 80% of the parent compounds still remaining at the conclusion of the 
experiment.  
 
Table 3.2. Total contaminant mass (%) remaining at each time point over the course of 
the experiment. 
 Time Point (days) 
 0 1 2 4 7 14 29 56 120 
LV Wash 100 103 ND* 92 86 70 47 39 28 
LV Bay 100 99 102 102 102 95 86 68 49 
DW Intake 100 102 97 96 95 85 79 66 60 
Colo River 100 99 92 97 92 86 83 71 63 
LV Bay Control 100 98 96 101 102 90 88 81 80 
 
ND* = No data for this time point due to failure of SPE pump.  Percent contaminant remaining 
calculated as Ct/C0, where Ct = sum of the total mass of the 27 compounds at each individual time 
point, and C0 = sum of the total mass of the compounds at the beginning of the experiment. 
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Analysis of the steroid estrogens, the compounds with the highest EDC potential 
(Routledge & Sumpter 1996), revealed that estrone, estradiol, and progesterone were 
reduced to below detection limits after 120 days in all samples with the exception of the 
control (which still contained 10% and 128% of estrone and estradiol, respectively) 
(Table 3.3).  Although estradiol was almost completely removed by the end of the 120 
day incubation in the control microcosm, it appears that it was converted to estrone, given 
the stoichiometric increase of this compound in the control (Fig. 3.2).  This could likely 
be due to abiotic transformation of estradiol to estrone, as this has previously been 
reported in the literature by Sheng et al. (2009), who showed complete abiotic oxidation 
of estradiol to estrone due to manganese in autoclaved soil samples.  Ethinylestradiol, 
which was reduced in concentration but persisted in all samples throughout the duration 
of the experiment, saw greatest reduction in the Las Vegas Wash microcosm.   
As was noted earlier, caffeine has been previously utilized as a wastewater tracer 
due to its reported refractory characteristics in surface water (Buerge et al., 2003).  
However, the Las Vegas Wash and Las Vegas Bay microcosms exhibited almost 
complete removal with 14% and 0% remaining, respectively.  A similar pattern was 
obtained for the antianxiety drug, meprobamate.  Consistent with the previously reported 
recalcitrance to degradation in surface waters noted by Snyder et al. (2004), after 120 
days no degradation was observed for three of the four sites tested.  In marked contrast, 
however, this compound was effectively removed from the Las Vegas Wash microcosm, 
with only 6%, remaining after 120 days (Table 3.3).  
Although degradation of some compounds was observed in the Las Vegas Bay 
bacteriostatic control microcosm, this loss could be due to abiotic processes such as 
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chemical oxidation, volatilization, or hydrolysis.  In the current experiment, the 
bacteriostatic agent used in the control was 1% sodium azide.  This compound has been 
used extensively as an industrial and experimental preservative as well as bacteriostatic 
agent since at least 1891 (Loew).  Keilin and Hartree (1934) demonstrated that sodium 
azide interferes with cellular metabolism by inhibiting cytochrome oxidase, the terminal 
electron transport complex in aerobic organisms.  Lichstein and Soule (1943) reported 
that lower concentrations of sodium azide (0.005 to 0.02%) were sublethal, and decreased 
aerobic respiration of bacteria.  However, higher concentrations (1%) have been shown to 
be bacteriostatic to both aerobes and anaerobes in liquid media, and bactericidal to many 
organisms including Bacillus subtilis, E. coli, and Clostridium perfingens (Forget and 
Fredette, 1962).  Due to its affordability, ease of use, and relatively safe disposal (unlike 
other bactericides, such as HgCl), sodium azide is often used to provide an abiotic control 
in biodegradation tests (Patterson et al., 2010, Bergheim et al., 2011, Murialdo et al., 
2003).  In addition to these benefits, it was also chosen in this experiment instead of 
autoclaving, over concern that the heat and pressure could potentially alter the natural 
organic matter and sorption potential of the treated sample. 
Removal via sorption was not specifically examined in this study, however, a 
similar study conducted by Benotti and Brownawell (2009), examined loss of 
pharmaceuticals due to sorption on suspended sediment particles using adsorption 
experiments.  After testing 19 pharmaceuticals, many of which overlap with those used in 
this study, they determined an average fraction of 0.92 of the original compounds which 
remained dissolved in solution, indicating sorption was insignificant.  Therefore, it is 
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unlikely that sorption played a major role in the loss of any compounds seen in the 
current study.   
Table 3.3. Total % remaining of parent compound after incubation for 120 days.  
 
    LV Wash LV Bay DW Intake 
Colorado 
River 
LV Bay 
Control 
Diazepam 
Anti-anxiety 
82 65 47 54 76 
Meprobamate 6 100 103 106 106 
Carbamazepine 
Anti-
convulsant 
76 85 105 88 69 
Phenytoin 14 122 74 104 84 
Primidone 95 108 108 96 97 
Caffeine Stimulant 14 0 85 104 109 
Fluoxetine Anti-depressant 53 20 3 22 64 
Ibuprofen 
NSAID 
0 0 1 9 103 
Naproxen 0 0 26 0 93 
Diclofenac 30 26 84 77 53 
Atorvastatin Anti-
lipidemic 
8 48 17 45 73 
Gemfibrozil 4 96 100 100 100 
Atenolol Beta blocker 0 3 44 9 81 
Iopromide X-ray contrast 0 89 190 71 148 
Sulfamethoxazole 
Antibiotic 
5 91 113 116 82 
Trimethoprim 4 81 83 50 82 
TCEP Flame retardant 87 82 53 83 67 
Bisphenol A Plastic component 7 0 9 76 90 
BHA Food preservative 0 2 0 2 0 
Atrazine Herbicide 83 76 68 72 62 
DEET Insect repellant 11 93 86 115 107 
Triclosan Antimicrobial 0 34 44 34 71 
Estradiol 
Steroid 
hormone 
0 0 0 0 10 
Estrone 0 0 0 0 128 
Ethynylestradiol 32 61 61 48 62 
Progesterone 0 0 0 0 0 
Testosterone 0 0 0 0 0 
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Figure 3.2. Degradation curves for bisphenol A, estradiol, and estrone.  Error bars 
represent  analytical error.  For additional compound figures, see Appendix.  
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Figure 3.3. Degradation curves for caffeine, atrazine, and meprobamate.  Error bars 
represent analytical error.  For additional compound figures, see Appendix.  
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Characterization of the Microbial Community 
Community diversity and richness 
Table 3.4 shows the results of the analysis of the 16S rRNA gene library coverage 
for planktonic microbial communities collected from each of the four sites at the 
beginning of the incubation.  OTUs are given for unique sequences and those roughly 
corresponding to the species, genus, and phylum levels (97%, 90% and 80%, 
respectively).  There were a total of 268 non-chimeric sequences among the four sites 
(Table 3.4).  Sites ranged from 32 – 40 observed OTUs and 63 – 90 predicted OTUs at 
the species level.  Values for the Chao 1 richness estimator revealed that the Las Vegas 
Bay and Colorado River were higher than either the Drinking Water Intake or Las Vegas 
Wash at the species level, with values of 89.8 and 90.2, respectively as opposed to 63.0 
and 65.1.  Since the Chao 1 estimate values are much higher at the species level than the 
total number of OTUs, it is assumed that total coverage of bacterial richness was not 
observed.  Rarefaction curves performed at the species level (Fig. 3.4) show similar 
richness between all four sites, with no observable significant difference between them.  
Rarefaction curves also indicate sampling was not exhaustive. 
Diversity at the species level according to the Shannon index indicated similar 
levels among the four sites.  The Drinking Water was slightly greater (3.43) than the Las 
Vegas Wash (3.38), the Las Vegas Bay (3.21) and the Colorado River (3.16) (Table 3.4).  
The Simpson index, with values inversely related to diversity, indicated that the Colorado 
River bacterial community was slightly less diverse than the other three sites at the 
species level, which were all close in value (0.0308 -0.0363).  At higher phylogenetic 
levels, the Drinking Water Intake site exhibited the greatest diversity at the genus and the 
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phylum levels for the Shannon index.  Evenness did not vary appreciably between sites at 
any of the distance levels analyzed (0.55-0.69).   
 
Table 3.4. Diversity and richness estimates from 16S rRNA gene sequences.  
 
 LV Wash LV Bay DW Intake Colorado R 
 n=64 n=57 n=75 n=72 
aOTUs     
unique 47 48 71 71 
97% 37 32 40 35 
90% 24 24 35 27 
80% 14 12 18 13 
aShannon index (H’)     
unique 3.70 3.81 4.24 4.26 
97% 3.38 3.21 3.43 3.16 
90% 2.88 2.85 3.25 2.93 
80% 2.10 1.97 2.53 2.07 
aChao 1     
unique 110.0 184.7 513.2 1278.5 
97% 65.1 89.8 63.0 90.2 
90% 33.0 35.0 50.3 38.1 
80% 24.5 17.0 19.0 15.0 
bEvenness     
unique 0.67 0.68 0.69 0.69 
97% 0.65 0.64 0.64 0.62 
90% 0.63 0.62 0.63 0.62 
80% 0.55 0.55 0.61 0.56 
aSimpson index     
unique 0.0164 0.0069 0.0014 0.0004 
97% 0.0308 0.0363 0.0317 0.0509 
90% 0.0610 0.0658 0.0418 0.0610 
80% 0.1483 0.1704 0.0941 0.1616 
aDiversity and richness measurements were determined in MOTHUR (Schloss et al. 2009) 
bEvenness was calculated as E=H/Hmax, where Hmax =log2(S), and S = the total number of phylotypes 
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Fig 3.4. Rarefaction analysis of 16S rRNA clone libraries at distance level of 97%. LVW 
= Las Vegas Wash, LVB = Las Vegas Bay; DWI = Drinking water intake; COR = 
Colorado River.  
 
Community composition 
 
Bacterial groups from the four sites at the start of the incubation were assigned at 
the phylum level using the RPD classifier tool (Wang et al. 2007) (Fig 3.5).  In all, 
samples showed significant coverage among the recognized bacterial phyla, even though 
the rRNA gene libraries were relatively small (64, 57, 75, and 72, for the Las Vegas 
Wash, Las Vegas Bay, Drinking Water Intake, and Colorado River, respectively (see 
Table 3.4)).  Proteobacteria dominated the community from the Las Vegas Wash (68%, 
Fig. 3.5), whereas Las Vegas Bay showed an equal proportion of Bacteroidetes (33%) 
and Proteobacteria (33%).  Cyanobacteria were relatively uniformly distributed across the 
33 
 
dataset, although at a somewhat lower proportion in the Drinking Water Intake, as 
expected due to the lower depth of this site.  The Drinking Water site was the only site to 
contain Nitrospira and Gemmatimonadetes.  All sites contained Actinobacteria and a 
small proportion of Verrucomicrobia, with the exception of the Las Vegas Wash, which 
had none. 
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Figure 3.5. Phylum-level distributions assigned to sequences using the Ribosomal 
Database Project classifier tool (http://rdp.cme.msu.edu/classifier).  
 
Bacterial community compositions of the four microcosm environments were 
compared using the Unifrac distance matrix (Lozupone et al. 2006).  A UPGMA tree 
illustrated the uniqueness of the Las Vegas Wash bacterial community relative to the 
other sites (Fig. 3.6) with the Las Vegas Wash branch clearly distinct from the other site 
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branches.  Unifrac Significance Analysis further showed that the Las Vegas Wash 
community was significantly different than the other three sites (p< 0.01).  Analysis using 
LIBSHUFF statistical comparison in Mothur (Schloss et al. 2009), also showed 
significant differences (p<0.0001) between the Wash bacterial community and each of 
the other three sites (data not shown).  Comparison of bacterial community structure from 
the four sites was further examined using T-RFLP profiling (Fig. 3.7).  Conspicuous 
shared ribotypes exist between Las Vegas Bay and the Colorado River (130 bp, blue 
arrows, Fig. 3.7), and between Las Vegas Bay, the Drinking Water Intake, and the 
Colorado River (291 bp, red arrows, Fig. 3.7).   
 
Figure 3.6. Comparison of the bacterial community profiles.  Dendogram was created 
from the 16S rRNA gene library OTUs and the UPGMA method calculated in UNIFRAC 
(Lozupone et al. 2006). LVW = Las Vegas Wash, LVB = Las Vegas Bay; DW = 
Drinking water intake; COR = Colorado River.    
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Figure 3.7. Qualitative overview showing patterns of bacterial diversity across the 
sample set (T-RFLP profiles). Several prominent shared peaks are denoted at 130 bp 
(blue arrow) and 291 bp (red arrow).  
 
Phylogenetic trees summarized the phylogenetic relationships between library 
clones in the four datasets and their cultivated relatives (Fig. 3.8 and 3.9).  Many of the 
clone sequences were affiliated with isolates previously shown to be capable of pollutant 
biodegradation or isolated from contaminant containing sites.  This was evident 
particularly from the Las Vegas Wash community.  Within the phylum Proteobacteria, 
the class Epsilonproteobacteria was exclusively represented by Las Vegas Wash clones, 
two of which were 98% identical to Sulfurospirillum sp. str. JPD-1 (Acc. AY189928.1), a 
strain capable of biotransformation of tetrachloroethene.  Additionally, five other Las 
Vegas Wash clones were 99% related to the bacterium Sulfuricurvum kujiense str. YK-3 
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(Acc. AB080644.1), a sulfur-oxidizing chemolithoautotroph able to grow on crude oil.    
Three Las Vegas Wash clones contained phylotypes with 97% identity to Denitromonas 
aromaticus str. AS-7 (AB049763.1), an aromatic compound-degrading bacterium 
previously isolated from activated sludge belonging to the Betaproteobacteria class.  
Methylophilus sp. U33 (EU375653.1), a betaproteobacterial strain capable of degrading 
organic pollutants, was the closest isolate (95% identity) related to three Drinking Water 
Intake clones, eight Colorado River, and two Las Vegas Bay clones.  The 
trichloroethylene degrader, Bacterium C115 (AB167243.1), with 98% identity to the 
Colorado River clone COR 04G, in the Betaproteobacteria class, was isolated from a 
chemostat enrichment culture.  Other clones within the Betaproteobacteria class included 
two Las Vegas Wash clones with 97% identity to Azoarcus sp. LU1 (AJ007007.1), a 
bacterium isolated from a compost biofilter which is able to degrade toluene, and 
Burkholderia sp. str. IMER-A1-13 (FJ434112.1), which can catabolize aromatic 
compounds under oligotrophic conditions.  Two Drinking Water clones, 09B and 01G, 
were most closely related to Steroidobacter denitrificans str. FS (89% identity; 
EF605262.1).  This isolate, in the Gammaproteobacteria class, has steroid hormone-
degrading abilities.  Sphingomonas sp str. D12 (AB105809.1), within the 
Alphaproteobacteria class and a known estrogen-degrading bacterium, is 95% related to 
two Colorado River clones.  Agrobacterium sanguineum str. ATCC 25660 
(AB062105.1), also within the class Alphaproteobacteria, has the ability to degrade 
biphenyl and dibenzofuran, and has 99% identity to a Colorado River clone.  Holophaga 
foetida str. TMBS4-T (X77215.1), a strain able to degrade methoxylated aromatic 
compounds in the phylum Acidobacteria, is 91% related to the Colorado River clone 
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07D.  Within the Firmicutes phylum, one OTU from the Las Vegas Wash site shared 
97% identity to Paenibacillus sp. Sphe2 (AJ699168), a PAH-degrading bacterium 
isolated from a creosote-contaminated site (Kallimanas 2004).  The high occurrence of 
clones related to known contaminant-degrading bacteria, particularly in the Las Vegas 
Wash and Colorado River, suggests the presence of organisms at these sites with the 
ability to degrade or at a minimum tolerate xenobiotic compounds and contaminants, 
particularly those of an aromatic nature.  This is particularly noteworthy in lieu of the fact 
that the majority of the compounds used in this study are aromatic compounds 
themselves. 
 
Microbial functional diversity 
 
Results from the Biolog EcoPlates, which were used to estimate microbial 
functional diversity, demonstrated that the microbial community of the Las Vegas Wash 
was capable of using most (30 of 31) of the suite of carbon substrates provided (Table 
3.5).  In comparison, the Las Vegas Bay community was able to use little more than half 
(16) of the substrates, whereas the Drinking Water Intake and Colorado River were far 
lower, with an ability to utilize 5 and 3 of the substrates, respectively.  The Las Vegas 
Wash’s considerably greater metabolic diversity is consistent with other results showing 
the uniqueness of the Wash bacterial community relative to the other sites in addition to 
the relatively high number of Las Vegas Wash clones known for their degradation 
capabilities.   
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 COR_07D
 X77215.1_Holophaga_foetida
 DWI_04D (2 DWI/2 COR)
Acidobacteria
 DWI_02B
 02D_LVB (11 DWI/12 COR/5 LVB)
 05G_LVB (1 COR/1 LVB)
 GQ369058.1_Lamia_sp._T2-YC6790
 AB360448.1_Lamibacter_majanohamensis_str._NBRC_102561
 DWI_06B
 AY140240.1_Acidimicrobium_sp._str._Y0018
 X85212.1_Candidatus_Nostocoida_limicola_str._Ben18
 COR_09G (2 COR)
 08B_LVB (1 DWI/1 LVB)
 COR_06F
Actinobacteria
 AJ699168.2_Paenibacillus_sp._Sphe2
 08G_LVW
 02C_LVB (3 LVB)
 DWI_10F
 EU483154.1_Sporobacterium_sp._str._WAL_1855D
 EU887828.1_Clostridium_lituseburense_str._H17
 09F_LVW
Firmicutes
 COR_10A (2 COR)
 03G_LVW
 AY584573.1_Rhodobacter_sp._HTCC515
 06H_LVW
 AF082797.1_Hyphomonas_oceanitis_str._SCH-89
 11F_LVW (3 LVW)
 COR_02B (2 COR)
 AB105809.1_Sphingomonas_sp._str._D12
 COR_05E
 AB062105.1_Agrobacterium_sanguineum_str._ATCC_25660
 COR_07B
 AY730717.1_Brevundimonas_diminuta_str._130704W3
 03A_LVB
 DWI_11F (9 DWI/4 COR)
 AF510191.1_Candidatus_Pelagibacter_ubique_str._HTCC1062
 08C_LVB
 04F_LVW
 DWI_09C
 AF069496.1_Candidatus_Odyssella_thessalonicensis_str._L13
 DWI_11A
 COR_11C
 AM991117.1_Roseomonas_sp._str._SK_65
Alphaproteobacteria
 DWI_09B (2 DWI)
 EF605262.1_Steroidobacter_denitrificans_str._FS
 DWI_01G (3 DWI)
Gammaproteobacteria
 U32940.1_Thiothrix_ramosa
 12G_LVW Gammaproteobacteria
 EF599315.1_Gamma_proteobacterium_E11
 01E_LVW (3 LVW) Gammaproteobacteria
 AB074518.1_Aquaspirillum_serpens_str._IAM_13944
 COR_10D (3 DWI/8 COR/2 LVB)
 EU375653.1_Methylophilus_sp._str._u33
 DWI_10A (4 DWI)
 AB089481.1_Derxia_gummosa_str._IAM_14990
 03A_LVW (2 LVW)
 11B_LVW (2 LVW)
 COR_01D (2 COR)
 COR_11E (2 COR/3 LVB)
 FJ434112.1_Burkholderia_sp._str._IMER-A1-13_BCB66
 COR_08F
 FJ999570.1_Limnobacter_thiooxidans_strain_HLSB157
 10C_LVW (2 LVW)
 AJ007007.1_Azoarcus_sp._LU1
 DWI_04G (2 DWI)
 AB049763.1_Denitromonas_aromaticus_str._AS-7
 10B_LVW (3 LVW)
 DWI_06C
 AF035054.1_Aquabacterium_commune_str._B8
 COR_04G
 AB167243.1_str._c115
 HE600664.1_Limnohabitans_sp._2KL-15
 COR_07H (4 COR)
 AM990763.1_Acidovorax_sp._MOLA_540
 05H_LVW (2 LVW)
 DQ372987.1_Aquaspirillum_sp._str._EMB325
 12C_LVW (3 LVW)
Betaproteobacteria
 06A_LVW (2 LVW)
 AY189928.1_Sulfurospirillum_sp._str._JPD-1
 12E_LVW (5 LVW)
 AB080644.1_Sulfuricurvum_kujiense_str._YK-3
 12F_LVW (3 LVW)
 AM084114.1_Arcobacter_sp._str._R-28314
 01A_LVW
Epsilonproteobacteria
 Bacteriodetes
 06B_LVW
 Nitrospira
 Gemmatimonadetes
 Verrucomicrobia
 06B_LVB
 DWI_04B
 Cyanobacteria
 AJ309733-1_Aquifex_aeolicus_16S
 M59126-1_Methanococcus_jannaschii_16S_ribosomal_RNA
0.05  
Fig. 3.8.  Maximum-likelihood tree with Bacteriodetes, Nitrospira, Gemmatimonadetes, 
Verrucomicrobia, and Cyanobacteria compressed.  
 
LVW 
LVB 
DWI 
COR 
Multiple Sites 
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 Acidobacteria
 Actinobacteria
 Firmicutes
 Alphaproteobacteria
 Gammaproteobacteria
 Gammaproteobacteria
 Gammaproteobacteria
 Betaproteobacteria
 Epsilonproteobacteria
 DWI_12B (3 DWI/1 COR)
 01G_LVW (2 LVW)
 EF148839.1_sp._str._OF1
 DWI_04E (2 DWI/2 LVB)
 04D_LVW
 12B_LVW (12 LVW)
 AB426577.1_Flavobacterium_sp._str._INBF006
 04C_LVB (1 COR/1 LVB)
 AB125062.1_Owenweeksia_hongkongensis_str._UST20020801
 02B_LVB
 01A_LVB (2 DWI/2 COR/4 LVB)
 COR_12F
 EU131006.1_Sphingomonas_sp._BAC84
 DWI_09G
 AY647897.1_Hymenobacter_sp._str._29F
 07H_LVB (3 LVB)
 03E_LVB
 EU313811.1_Chimaereicella_sp._str._A8-7
 COR_12C
 AJ784892.1_Haliscomenobacter_hydrossis_str._DSM_1100___ATCC_27775
 12F_LVB
 01B_LVW
 AB470450.1_Sediminibacterium_sp._str._TEGAF015
 COR_03E (1 DWI/1 COR)
 COR_02E (1 DWI/3 COR/3 LVB)
 COR_04B (2 COR)
 FJ177533.1_Flavosolibacter_sp._str._HU1-JC5
 03B_LVB (1 DWI/1 LVB)
 05F_LVW
Bacteroidetes
 06B_LVW
 AF035813.1_nitrifying_sludge_clone_Hovanec
 DWI_08C (4 DWI) Nitrospira
 DWI_03F
 AB072735.1_Gemmatimonas_aurantiaca Gemmatimonadetes
 DWI_12E
 DWI_02A (2 DWI/1 LVB)
 05H_LVB (1 DWI/1 LVB)
 COR_02A
 ABVL01000001.1_Chthoniobacter_flavus_str._Ellin428
 DWI_07G (2 DWI)
 DWI_12F (3 DWI)
Verrucomicrobia
 06B_LVB
 DWI_04B
 03C_LVW (3 LVW)
 05C_LVW
 DQ293994.1_Pleurocapsa_sp._str._CALU_1126
 EF088334.1_Synechococcus_sp._str._CENA_108
 DWI_07H (2 DWI/1 COR/2 LVB)
Cyanobacteria
 AJ309733-1_Aquifex_aeolicus_16S
 M59126-1_Methanococcus_jannaschii_16S_ribosomal_RNA
0.05  
Fig. 3.9. Maximum-likelihood tree with Acidobacteria, Actinobacteria, Firmicutes, and 
Proteobacteria compressed.   
 
 
Table 3.5. Community metabolic diversity using Biolog EcoPlates at T=0. 
 
Substrate  
LV 
Wash LV Bay 
DW 
Intake Colo. R Control 
Water   
pyruvic acid methyl ester X X   
Tween 40 X X X  
Tween 80 X  X  
alpha-clyclodextrix X    
glycogen X X  X 
D-cellulose X X   
alpha-D-lactose X X   
LVW 
LVB 
DWI 
COR 
Multiple Sites 
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Substrate  
LV 
Wash LV Bay 
DW 
Intake Colo. R Control 
beta-methyl-D-glucoside X    
D-xylose X    
i-erythritol X X   
D-mannitol X X  X 
n-acetyl-D-glucosamine X X   
D-glucosaminic acid X    
glucose-1-phosphate X    
D,L-alpha-glycerol phosphate X    
D-galactonic acid gamma-lactone X X   
D-galacturonic acid X  X X 
2-hydroxy benzoic acid     
4-Hydroxy Benxoic acid X X X  
gamma-hydroxuybutyric acid X  X  
itaconic acid X    
alpha-ketobutyric acid X X   
D-malic acid X    
L-arginine X X   
L-asparagine X X   
L-phenylalanine X    
L-serine X X   
L-threonine X X   
glycyl-L-glutamic acid X X   
phenylethylamine X    
putrescine X   
Total substrates used 30 16 5 3 0 
 
 
Bacterial counts 
 
Bacterial abundance was measured at the initiation of the experiment using both 
flow cytometry and heterotrophic plate counts (HPCs).  Cell counts from the initial time 
point of the experiment (Table 3.6) were greatest for the Las Vegas Wash site for both 
flow cytometry counts (viable and non-viable) and HPCs, numbering 3.4 X 105 and 1.2 X 
105 mL-1, respectively.  The Drinking Water Intake had by far the lowest numbers of 
cells, with almost an order of magnitude lower cell counts than the Wash as measured by 
flow cytometry, and far lower HPCs, with only 2.0 X 102 mL-1.  The Las Vegas Bay (with 
1.1 X 105 mL-1), and consecutively, the Colorado River (with 2.5 X 105 mL-1) each had 
slightly higher counts than the Drinking Water Intake with regard to flow cytometry 
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values.  HPC numbers were again, far lower at these sites when compared to the Wash 
(8.7 X 102 and 2.0 X 102 mL-1, respectively).  These values are generally consistent with 
the literature as HPCs have been shown to be 1 – 4 orders of magnitude lower than those 
observed for flow cytometry counts of raw surface and drinking waters (Hoefel et al. 
2003, Hammes et al. 2008).  This is not unexpected as it is generally acknowledged that 
only a small percentage of environmental bacteria are culturable using current 
methodologies (Amann et al. 1995, Oliver 2005).  Therefore, it is somewhat surprising to 
see such a close agreement between the HPC and flow cytometry counts for the Las 
Vegas Wash site.  It is possible that heterotrophic bacteria are more abundant and occur 
in higher proportions in the Wash due to the higher nutrient concentrations at this 
location.  Additionally, the higher metabolic diversity of the Las Vegas Wash as seen 
from the EcoPlates, could be attributable to the higher density of heterotrophic bacteria 
from this site and their ability to utilize a more diverse set of carbon substrates.    
 
Table 3.6. Cell counts (mL-1) at initiation of microcosm experiment using flow cytometry 
and heterotrophic plate counts (HPCs). 
 
 LV Wash Colorado R DW Intake LV Bay 
aFlow cytometry 3.4E+05 2.5E+05 5.6E+04 1.1E+05 
HPC 1.2E+05 2.4E+03 2.0E+02 8.7E+02 
aFlow cytometry counts include both viable and non-viable cells 
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CHAPTER 4 
CONCLUSIONS 
This study examined the degradation potential of 27 pharmaceuticals and EDCs 
from four sites differentiated by their proximity to a wastewater effluent source.  The 
goals of the study were to identify what roles bacterial community composition, diversity, 
and abundance had relative to pharmaceutical and EDC degradation.  Of the four 
microcosms, the greatest overall contaminant removal occurred in the Las Vegas Wash, 
with 72% overall compound mass reduction after 120 days.  The other microcosms 
exhibited removal to a lesser extent, with 51%, 40%, and 37% for the Las Vegas Bay, 
Drinking Water Intake, and the Colorado River microcosm, respectively (Table 3.2).  The 
metabolic potential of microorganisms from the four sites measured with Biolog 
Ecoplates showed a similar pattern, with the Wash community able to use a more 
extensive range of carbon substrates than any other microcosm community (Table 3.5).  
Furthermore, community composition analysis using Unifrac (Fig 3.6) and Libshuff 
statistical methods revealed the Las Vegas Wash phylotypes to be significantly distinct 
from those of any other site, although there was little difference between the microcosms 
with regard to diversity and richness.  Water chemistry parameters also distinguished the 
Las Vegas Wash site from the others due to the higher concentrations of nutrients 
including carbon, nitrogen, and phosphorus.  Due to the higher nutrient availability in the 
Las Vegas Wash, it is difficult to differentiate whether the higher degradation potential 
exhibited by the Wash microcosm was due to the microbial community itself, or to a 
more nutrient-favorable environment better suited to heterotrophic activity and 
subsequent biodegradation.  However, 16S rRNA gene libraries did indicate a greater 
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number of phylotypes related to known isolates with biodegradation abilities, which 
indicates that microorganisms from the Las Vegas Wash have a greater metabolic 
potential for EDC catabolism.  
Future studies of this type could correct for this ambiguity by providing 
microcosms supplied with the same nutrient and water chemistry parameters, with 
different microbial community inocula standardized to the same initial cell concentration.  
Additionally, nutrients and other abiotic parameters such as pH and temperature could be 
amended to determine which conditions might favor enhanced degradation.   
Furthermore, due to the fact that many contaminants are hydrophobic in nature, 
experiments with microcosms looking at the sediment water interface and any associated 
microbial biofilms would likely be useful. 
Finally, while primary degradation information can assist in estimating the fate 
and transport of these compounds, there is still very little known about the metabolites, 
pathways, and transformation products formed as a result of initial biodegradation. 
Transformation by bacteria can often cause an increase in toxicity and/or estrogenicity of 
some compounds (i.e. when mercury or triclosan becomes methylated (Schwarzenbach et 
al. 2006)). Toxicity Identification Evaluations (TIEs) and metabolite identification would 
be helpful in determining if the primary degradation reduced the toxicity or estrogenicity 
of the water samples.   
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APPENDIX 
 
 
Table A.1. Water Quality Data 
 Las Vegas Wash 
Las Vegas 
Bay DW Intake 
Colorado 
River 
Tot. Alkalinity (mg/L) 129 132 143 134 
Ammonia (mg/L N) 0.205 0.024 <0.02 <0.02 
Boron (mg/L) 0.57 0.12 0.1 <0.1 
Bromide (mg/L) 0.99 0.09 0.0817 0.0693 
Chloride (mg/L) 340 100 88 80 
Conductivity (μs/cm) 2433 1068 1030 908 
DO (mg/L) 6.57 7.81 5.87 8.57 
Fluoride (mg/L) 0.9 0.35 0.33 0.31 
Iron (mg/L) <0.1 <0.1 <0.1 <0.1 
Calcium (mg/L) 130 75 81 69 
Magnesium (mg/L) 63 28 27 24 
Potassium (mg/L) 32 6.9 5.9 5 
Sodium (mg/L) 280 99 96 81 
Tot. Hardness (mg/L CaCO3) 590 300 320 270 
Nitrate (mg/L N) 14 0.88 0.5 0.2 
Nitrite (mg/L N) <0.05 <0.05 <0.05 <0.05 
pH 7.71 8.27 7.93 8.38 
o-Phosphate (mg/L P) 0.098 <0.001 0.0014 <0.001 
T-Phosphate (mg/L P) 0.12 <0.005 <0.005 0.0055 
Silica (mg/L) 19 6.7 7.3 6.2 
Sulfate (mg/L) 570 270 250 220 
TDS (mg/L) 1541 649.4 618.4 553.6 
Temperature (°C) 23.4 21.6 17.8 20.8 
TOC (mg/L) 6.0 3.2 2.7 2.9 
Aluminum (mg/L) 0.072 <0.005 <0.005 0.037 
Antimony (mg/L) <0.0006 <0.0006 <0.0006 <0.0006 
Arsenic (mg/L) 0.0069 0.0028 0.0022 0.0023 
Barium (mg/L) 0.066 0.13 0.15 0.13 
Beryllium (mg/L) <0.0004 <0.0004 <0.0004 <0.0004 
Cadmium (mg/L) <0.0005 <0.0005 <0.0005 <0.0005 
Chromium (mg/L) <0.005 <0.005 <0.005 <0.005 
Copper (mg/L) 0.025 <0.005 0.012 <0.005 
Lead (mg/L) <0.001 <0.001 <0.001 <0.001 
Manganese (mg/L) 0.04 <0.005 <0.005 <0.005 
Mercury (mg/L) <0.0002 0.0002 <0.0002 <0.0002 
Molybdenum (mg/L) 0.02 0.0062 0.0051 <0.005 
Nickel (mg/L) 0.0057 <0.005 <0.005 <0.005 
Selenium (mg/L) 0.0036 0.0024 0.0022 0.0022 
Silver (mg/L) <0.005 <0.005 <0.005 <0.005 
Thallium (mg/L) <0.0002 <0.0002 <0.0002 <0.0002 
Vanadium (mg/L) <0.005 <0.005 <0.005 <0.005 
Zinc (mg/L) 0.037 <0.005 0.029 <0.005 
TSS (mg/L) <5 <5 <5 <5 
Turbidity (NTU) 2.68 0.51 0.33 2.66 
UV254 (cm-) 0.1000 0.0404 0.0417 0.0511 
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Table A.2. Background concentrations in Las Vegas Wash before spike mix. 
 
RAW DATA - SAMPLES BEFORE SPIKE 
Date Collected 
10/21/2008 
9:05 
10/23/2008 
15:00 
Location LV Wash LV Wash 
Sub Location  T=Oa 
Tap Location   
Sulfamethoxazole 990 1000 
Atenolol 630 670 
Trimethoprim 58 59 
Iopromide 25 <10 
Caffeine 14 14 
Fluoxetine 12 9.1 
Meprobamate 580 560 
Dilantin 130 180 
Carbamazepine 160 190 
Atrazine 0.68 <.25 
Diazepam 4.4 2.9 
Atorvastatin 6.1 6.6 
Benzophenone 83 90 
Primidone 150 140 
TCPP 1700 1400 
DEET 120 96 
TCEP 540 490 
Gemfibrozil 110 120 
Bisphenol A <5 <5 
Diclofenac 39 69 
Naproxen 79 88 
Triclosan 25 15 
Octylphenol <25 <25 
BHA 3.9 <1 
Musk Ketone <25 40 
Ibuprofen 6.3 6 
Testosterone <.5 <.5 
Progesterone <.5 <.5 
Estrone <.2 <.2 
Estradiol <.5 <.5 
Ethynylestradiol <1 <1 
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Table A.3. Background concentrations in Drinking Water Intake before spike mix. 
 
 
RAW DATA - SAMPLES BEFORE SPIKE 
Date Collected 
10/21/2008 
9:27 
10/23/2008 
15:00 
Location IPS 2 IPS 2 
Sub Location  T=Oa 
Tap Location   
Sulfamethoxazole 18 20 
Atenolol <1 1.1 
Trimethoprim 0.4 0.71 
Iopromide <10 <10 
Caffeine <5 5.4 
Fluoxetine <.5 <.5 
Meprobamate 10 10 
Dilantin 2.6 2.5 
Carbamazepine 3.4 2.8 
Atrazine 1.1 1.1 
Diazepam <.25 <.25 
Atorvastatin <.5 <.5 
Benzophenone <50 <50 
Primidone 2.8 3 
TCPP <100 <100 
DEET 5.2 5.1 
TCEP <10 <10 
Gemfibrozil 0.26 <.25 
Bisphenol A <5 <5 
Diclofenac <.5 <.5 
Naproxen <.5 <.5 
Triclosan <1 1.1 
Octylphenol <25 <25 
BHA <1 <1 
Musk Ketone <25 <25 
Ibuprofen <1 <1 
Testosterone <.5 <.5 
Progesterone <.5 <.5 
Estrone <.2 <.2 
Estradiol <.5 <.5 
Ethynylestradiol <1 <1 
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Table A.4. Background concentrations in Colorado River before spike mix. 
 
RAW DATA - SAMPLES BEFORE SPIKE 
Date Collected 
10/22/2008 
11:00 
10/23/2008 
15:00 
Location Up Co. Riv. Up Co. Riv. 
Sub Location  T=Oa 
Tap Location   
Sulfamethoxazole 6.8 7 
Atenolol <1 <1 
Trimethoprim <.25 <.25 
Iopromide <10 <10 
Caffeine 6 5.2 
Fluoxetine <.5 <.5 
Meprobamate 2.4 2.3 
Dilantin <1 1.6 
Carbamazepine 0.96 1.1 
Atrazine 1.2 0.98 
Diazepam <.25 <.25 
Atorvastatin <.5 <.5 
Benzophenone <50 <50 
Primidone 0.77 0.57 
TCPP <100 <100 
DEET 15 3.6 
TCEP <10 <10 
Gemfibrozil <.25 <.25 
Bisphenol A <5 <5 
Diclofenac <.5 <.5 
Naproxen <.5 <.5 
Triclosan 12 1.9 
Octylphenol <25 <25 
BHA <1 <1 
Musk Ketone <25 <25 
Ibuprofen <1 <1 
Testosterone <.5 <.5 
Progesterone <.5 <.5 
Estrone <.2 <.2 
Estradiol <.5 <.5 
Ethynylestradiol <1 <1 
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Table A.5. Background concentrations in Las Vegas Bay before spike mix. 
 
RAW DATA - SAMPLES BEFORE SPIKE 
 
10/23/2008 
9:30 
10/23/2008 
15:00 
 
LAKE 
MEAD/BB LVB 6.7 
 LVB6.7 T=Oa 
Tap Location 0M  
Sulfamethoxazole 38 37 
Atenolol 5.6 6.1 
Trimethoprim <.25 <.25 
Iopromide <10 <10 
Caffeine 51 140 
Fluoxetine 0.52 <.5 
Meprobamate 26 28 
Dilantin 5.4 6 
Carbamazepine 6.3 6.5 
Atrazine 0.32 <.25 
Diazepam <.25 <.25 
Atorvastatin <.5 <.5 
Benzophenone <50 <50 
Primidone 6.3 6.7 
TCPP <100 <100 
DEET 22 9.3 
TCEP <10 <10 
Gemfibrozil <.25 <.25 
Bisphenol A <5 19 
Diclofenac <.5 <.5 
Naproxen <.5 0.5 
Triclosan <1 <1 
Octylphenol <25 <25 
BHA <1 <1 
Musk Ketone <25 <25 
Ibuprofen <1 <1 
Testosterone <.5 <.5 
Progesterone <.5 <.5 
Estrone <.2 <.2 
Estradiol <.5 <.5 
Ethynylestradiol <1 <1 
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Table A.6. Raw data values for compound concentrations at each site after spike was 
added for Las Vegas Wash.  
 
 Total Concentrations      
day 0 1 4 7 14 29 56 120 
Sulfameth. 1200 1300 1300 1400 1400 1400 33 58 
Atenolol 800 850 640 340 <4 <4 <4 <4 
Trimethoprim 310 340 320 310 290 81 32 13 
Iopromide 200 580 430 300 100 <40 <40 <40 
Caffeine 460 490 450 500 530 360 220 64 
Fluoxetine 190 210 200 190 210 170 140 100 
Meprobamate 840 790 840 830 600 53 41 49 
Dilantin 580 500 460 410 410 360 360 81 
Carbamazepine 410 440 420 430 390 350 370 310 
Atrazine 240 300 250 260 230 220 200 200 
Diazepam 340 350 310 350 370 340 320 280 
Atorvastatin 230 210 240 250 210 70 32 18 
Primidone 420 390 380 400 400 400 380 400 
DEET 210 270 220 210 200 9.9 10 23 
TCEP 670 640 670 670 610 580 570 580 
Gemfibrozil 340 350 350 350 340 290 200 15 
Bisphenol A 360 340 210 180 30 21 <5 27 
Diclofenac 370 410 370 370 260 250 220 110 
Naproxen 350 380 360 360 350 180 85 <2 
Triclosan 80 94 66 49 39 <4 <1 <4 
BHA 140 170 93 66 31 15 <1 <4 
Ibuprofen 310 340 300 250 210 100 <1 <4 
Testosterone 296 20 <2 <2 <2 <2 <2 <2 
Progesterone 27 <2 <2 <2 <2 <2 <2 <2 
Estrone 22 26 28 9.3 <.8 <.8 <.8 <.8 
Estradiol 60 39 5.7 <2 <2 <2 <2 <2 
Ethynylestradiol 148 138 131 128 94 108 70 48 
Total ng/L 8404 8666 7744 7212 5904 3958 3250 2318
Total % 
removal 0 -3 8 14 30 53 61 72
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Table A.7. Raw data values for compound concentrations at each site after spike was 
added for Las Vegas Bay.  
 
 Total Concentrations       
day 0 1 2 4 7 14 29 56 120 
Sulfameth. 340 360 390 410 350 400 380 390 310 
Atenolol 260 250 240 280 250 260 210 77 8.9 
Trimethoprim 270 300 310 300 320 290 280 260 220 
Iopromide 380 320 380 330 360 410 350 210 340 
Caffeine 560 580 590 560 510 710 600 150 <20 
Fluoxetine 250 230 240 230 210 210 170 110 51 
Meprobamate 330 350 350 370 370 350 350 360 330 
Dilantin 230 250 320 290 340 280 290 290 280 
Carbamazepine 270 240 300 290 270 230 250 210 230 
Atrazine 210 240 240 260 250 250 220 180 160 
Diazepam 340 310 360 360 340 350 300 280 220 
Atorvastatin 230 210 220 230 240 170 150 160 110 
Primidone 240 290 240 250 320 260 260 290 260 
DEET 140 160 140 150 140 160 160 170 130 
TCEP 170 190 170 210 220 110 120 94 140 
Gemfibrozil 240 260 240 240 260 230 270 240 230 
Bisphenol A 320 330 310 330 320 290 290 260 <20 
Diclofenac 420 430 450 490 510 280 270 320 110 
Naproxen 270 270 280 290 310 280 280 250 <2 
Triclosan 76 74 67 65 67 65 60 38 26 
BHA 340 340 290 300 290 180 78 36 6.5 
Ibuprofen 330 300 320 300 320 340 230 <1 <4 
Testosterone 115 12.9 <2 <2 <2 <2 <2 <2 <2 
Progesterone 32.6 10.1 <2 <2 4.38 <2 <2 <2 <2 
Estrone 61.9 83.3 86.8 72.8 45.3 26.3 <.8 <.8 <.8 
Estradiol 23.6 5.51 <2 <2 <2 <2 <2 <2 <2 
Ethynylestradiol 140 157 160 136 125 115 119 109 85.6 
Total ng/L 6589 6553 6694 6744 6742 6246 5687 4484 3248
Total % 
removal 0 1 -2 -2 -2 5 14 32 51
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Table A.8. Raw data values for compound concentrations at each site after spike was 
added for Las Vegas Bay Sterile Control.  
 
 Total Concentrations       
day 0 1 2 4 7 14 29 56 120 
Sulfameth. 380 340 360 390 350 400 410 370 310 
Atenolol 270 310 260 280 260 270 270 270 220 
Trimethoprim 280 270 290 280 330 260 260 250 230 
Iopromide 290 320 210 450 550 290 320 280 430 
Caffeine 550 540 560 540 570 680 680 580 600 
Fluoxetine 250 250 230 240 260 260 220 190 160 
Meprobamate 350 320 360 360 350 340 370 350 370 
Dilantin 320 280 260 240 310 270 320 310 270 
Carbamazepine 290 290 270 270 270 220 230 230 200 
Atrazine 260 220 220 250 250 250 210 180 160 
Diazepam 330 330 330 350 360 340 310 280 250 
Atorvastatin 220 210 210 220 230 190 220 160 160 
Primidone 310 270 260 260 350 290 270 270 300 
DEET 140 150 140 140 140 170 170 160 150 
TCEP 210 210 200 300 220 150 130 110 140 
Gemfibrozil 250 250 250 280 250 270 230 250 250 
Bisphenol A 300 340 280 340 320 340 270 280 270 
Diclofenac 490 440 460 430 430 290 270 280 260 
Naproxen 290 280 300 290 280 280 280 250 270 
Triclosan 76 70 68 70 71 84 74 63 54 
BHA 310 320 310 270 200 100 22 <1 <4 
Ibuprofen 300 320 310 310 310 280 300 310 310 
Testosterone 141 166 190 177 108 <2 <2 <2 <2 
Progesterone 31.7 29.5 30.1 26.2 24.9 <2 16 <2 <2 
Estrone 49.1 36.2 33.1 29.5 38.7 56.1 82.7 71.9 63 
Estradiol 28.8 35.9 42.3 37.9 33.1 16.3 <2 <2 2.84 
Ethynylestradiol 162 153 170 133 151 117 130 105 100 
Total ng/L 6879 6751 6604 6964 7017 6213 6065 5600 5530
Total % 
removal 0 2 4 -1 -2 10 12 19 20
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Table A.9. Raw data values for compound concentrations at each site after spike was 
added for Drinking Water Intake.  
 
 Total Concentrations       
day 0 1 2 4 7 14 29 56 120 
Sulfameth. 320 310 340 320 340 360 370 340 360 
Atenolol 270 240 260 270 260 270 260 190 120 
Trimethoprim 290 280 280 300 280 280 290 270 240 
Iopromide 210 320 380 390 400 300 290 310 400 
Caffeine 460 430 460 380 430 420 490 380 390 
Fluoxetine 240 250 250 240 240 180 91 31 7.4 
Meprobamate 320 330 350 340 340 400 380 290 330 
Dilantin 310 360 270 320 400 330 330 300 230 
Carbamazepine 190 250 230 280 250 240 250 200 200 
Atrazine 220 250 240 240 250 210 210 190 150 
Diazepam 340 410 370 370 330 310 320 260 160 
Atorvastatin 210 220 190 170 170 120 75 53 35 
Primidone 260 290 270 280 270 300 280 270 280 
DEET 140 130 150 140 130 150 140 130 120 
TCEP 190 190 200 210 270 140 140 100 100 
Gemfibrozil 250 240 240 250 250 240 230 240 250 
Bisphenol A 290 290 250 250 88 42 <20 <5 27 
Diclofenac 310 330 310 330 330 230 200 260 260 
Naproxen 270 290 270 270 270 260 260 230 69 
Triclosan 72 68 74 74 73 68 60 44 32 
BHA 320 330 250 220 200 120 45 15 <4 
Ibuprofen 310 300 280 300 300 280 200 14 4.4 
Testosterone 319 140 26 <2 <2 <2 <2 <2 <2 
Progesterone 32 12 <2 <2 <2 <2 <2 <2 <2 
Estrone 12 14 15 15 14 17 29 15 <.8 
Estradiol 70 69 68 41 36 23 3.9 <2 <2 
Ethynylestradiol 158 145 149 129 135 108 126 104 96 
Total ng/L 6384 6488 6172 6129 6056 5398 5070 4236 3860 
Total % 
removal 0 -2 3 4 5 15 21 34 40 
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Table A.10. Raw data values for compound concentrations at each site after spike was 
added for the Colorado River.  
 
day 0 1 2 4 7 14 29 56 120 
Sulfameth. 310 390 310 330 330 320 320 330 360 
Atenolol 270 270 260 240 260 220 190 87 24 
Trimethoprim 280 300 260 290 280 270 280 240 140 
Iopromide 410 430 470 500 320 350 270 150 290 
Caffeine 460 430 430 520 500 520 550 520 480 
Fluoxetine 250 250 230 220 220 180 180 98 55 
Meprobamate 310 350 300 320 320 340 340 350 330 
Dilantin 250 300 230 410 320 340 290 310 260 
Carbamazepine 250 280 260 260 260 230 230 220 220 
Atrazine 250 250 240 230 260 230 220 210 180 
Diazepam 370 330 340 320 330 320 280 260 200 
Atorvastatin 220 250 220 210 210 160 170 150 100 
Primidone 280 270 270 270 220 280 290 250 270 
DEET 130 120 130 150 150 140 140 120 150 
TCEP 180 230 190 190 200 160 160 76 150 
Gemfibrozil 250 270 220 240 260 240 240 230 250 
Bisphenol A 290 310 310 270 280 290 290 300 220 
Diclofenac 350 330 310 350 310 230 210 260 270 
Naproxen 290 260 270 260 270 260 260 150 <2 
Triclosan 80 70 72 75 67 54 42 39 27 
BHA 230 230 200 190 170 100 67 35 4.9 
Ibuprofen 310 310 290 290 290 250 260 160 27 
Testosterone 242 4.7 <2 <2 <2 <2 <2 <2 <2 
Progesterone 26 <2 <2 <2 <2 8.5 <2 <2 <2 
Estrone 31 38 17 1.3 <.8 <.8 <.8 <.8 <.8 
Estradiol 42 11 <2 <2 <2 <2 <2 <2 <2 
Ethynylestradiol 143 156 133 147 134 106 125 90 68 
Total ng/L 6504 6440 5962 6283 5961 5598 5404 4635 4076 
Total % 
removal 0 1 8 3 8 14 17 29 37 
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Figure A.1. Degradation curves at each site organized according to chemical compound 
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Carbamazepine
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Figure A.2. Degradation curves at each site organized according to chemical compound 
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Figure A.3. Degradation curves at each site organized according to chemical compound 
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Figure A.4. Degradation curves at each site organized according to chemical compound 
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Naproxen
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Figure A.5. Degradation curves at each site organized according to chemical compound 
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Atorvastatin
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Figure A.6. Degradation curves at each site organized according to chemical compound 
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Atenolol
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Figure A.7. Degradation curves at each site organized according to chemical compound 
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Figure A.8. Degradation curves at each site organized according to chemical compound 
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Bisphenol A
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Figure A.9. Degradation curves at each site organized according to chemical compound 
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BHA
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Figure A.10. Degradation curves at each site organized according to chemical compound 
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DEET
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Triclosan
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Figure A.11. Degradation curves at each site organized according to chemical compound 
 
65 
 
Estradiol
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Figure A.12. Degradation curves at each site organized according to chemical compound 
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Ethinylestradiol
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Figure A.13. Degradation curves at each site organized according to chemical compound 
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Testosterone
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Figure A.14. Degradation curves at each site organized according to chemical compound 
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